Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.34

€3.34

-6.610%
-0.506
-6.610%
€10.00

€10.00

 
19.04.21 / Tradegate WKN: A2PSNF / Symbol: NNVCE / Name: NanoViricides / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
-
27.08.20
€10.00
12.03.20
buy
Your prediction

NanoViricides Inc. Stock

Heavy losses for NanoViricides Inc. today as the stock fell by -€0.506 (-6.610%).
With 1 Sell predictions and 1 Buy predictions the community sentiment towards the NanoViricides Inc. stock is not clear.
Based on the current price of €3.34 the target price of €10.00 shows a potential of 199.043% for NanoViricides Inc. which would more than double the current price.

Pros and Cons of NanoViricides Inc. in the next few years

Pros
?
Market Position
?
Conscious of the environment
?
Brand
Cons
?
Growth compared to competition
?
Worthwhile Investment for the next years
?
Shareholder structure
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of NanoViricides Inc. vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
NanoViricides Inc. -6.610% -7.649% -15.708% -27.358% 41.825% - -
F-Star Therapeutics Inc. -14.060% 8.475% -4.950% - 17.864% - -
Immunic Inc. -6.880% -4.944% -5.397% 53.806% -17.222% - -
Reata Pharmaceuticals Inc 1.320% -3.822% -24.500% -44.485% -27.404% 327.520% -

Other discussions about NanoViricides Inc. Stock

New thread Forum

News

DGAP-News: NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2020 - Has Sufficient Cash, Coronavirus Drug Development Progress
DGAP-News: NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2020 - Has Sufficient Cash, Coronavirus Drug Development Progress